Literature DB >> 24182388

The ethics of surgically invasive neuroscience research.

Paul J Ford1, Abhishek Deshpande.   

Abstract

A clear understanding of distinctions and definitions is necessary before determining which types of surgically invasive neuroscience research should be permitted and how the experimental protocols can properly be undertaken. A failure to clarify the ethical distinctions in invasive neuroscience research hinders attempts at ethical analysis and guidance. At least four main distinctions need to be addressed: "invasiveness" as an important moral characteristic; special brain-mind-related risks; research participant selection; and ideologic interpretation of human function. Harm and not invasiveness is the metric by which to measure the ethical permissibility of research. Because of a class of harms to minds and selves, special attention should be paid to value considerations. These considerations need to be addressed by researchers, funders, and review boards to create proper safeguards from conception of research through final application of results.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  bioethics; deep brain stimulation; ethics; invasive; mind; neurologic surgery; research

Mesh:

Year:  2013        PMID: 24182388     DOI: 10.1016/B978-0-444-53501-6.00026-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

Review 1.  3D in vitro modeling of the central nervous system.

Authors:  Amy M Hopkins; Elise DeSimone; Karolina Chwalek; David L Kaplan
Journal:  Prog Neurobiol       Date:  2014-11-22       Impact factor: 11.685

2.  Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review.

Authors:  Saskia Hendriks; Christine Grady; Khara M Ramos; Winston Chiong; Joseph J Fins; Paul Ford; Sara Goering; Henry T Greely; Katrina Hutchison; Michael L Kelly; Scott Y H Kim; Eran Klein; Sarah H Lisanby; Helen Mayberg; Hannah Maslen; Franklin G Miller; Karen Rommelfanger; Sameer A Sheth; Anna Wexler
Journal:  JAMA Neurol       Date:  2019-10-17       Impact factor: 29.907

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.